Competing endogenous RNA network and prognostic nomograms for hepatocellular carcinoma patients who underwent R0 resection

被引:9
作者
Li, Yuntong [1 ]
Ma, Bingfen [2 ]
Yin, Zhenyu [1 ]
Liu, Pingguo [1 ]
Liu, Jianming [1 ]
Li, Jie [1 ]
Wang, Fuqiang [1 ]
Chen, Huimin [1 ]
机构
[1] Xiamen Univ, Dept Hepatobiliary Surg, Zhongshan Hosp, Xiamen 361004, Fujian, Peoples R China
[2] Xiamen Univ, Siming Branch, Dept Internal Med, Affiliated Hosp 1, Xiamen 361003, Fujian, Peoples R China
基金
美国国家科学基金会;
关键词
competing endogenous RNA; early recurrence; hepatocellular carcinoma; nomogram; The Cancer Genome Atlas; MICROVASCULAR INVASION; RISK-FACTORS; INTRAHEPATIC RECURRENCE; LIVER RESECTION; SURVIVAL; IMMUNOTHERAPY; HEPATITIS; NIVOLUMAB; TUMOR; CERNA;
D O I
10.1002/jcp.28634
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The prognosis of hepatocellularcarcinoma (HCC) after R0 resection is unsatisfactory due to the high rate of recurrence. In this study, we investigated the recurrence-related RNAs and the underlying mechanism. The long noncoding RNA (lncRNA), microRNA (miRNA), and messenger RNA (mRNA) expression data and clinical information of 247 patients who underwent R0 resection patients with HCC were obtained from The Cancer Genome Atlas. Comparing the 1-year recurrence group (n=56) with the nonrecurrence group (n=60), we detected 34 differentially expressed lncRNAs (DElncRNAs), five DEmiRNAs, and 216 DEmRNAs. Of these, three DElncRNAs, hsa-mir-150-5p, and 11 DEmRNAs were selected for constructing the competing endogenous RNA (ceRNA) network. Next, two nomogram models were constructed based separately on the lncRNAs and mRNAs that were further selected by Cox and least absolute shrinkage and selection operator regression analysis. The two nomogram models that showed a high prediction accuracy for disease-free survival with the concordance indexes at 0.725 and 0.639. Further functional enrichment analysis of DEmRNAs showed that the mRNAs in the ceRNA network and nomogram models were associated with immune pathways. Hence, we constructed a hsa-mir-150-5p-centric ceRNA network and two effective nomogram prognostic models, and the related RNAs may be useful as potential biomarkers for predicting recurrence in patients with HCC.
引用
收藏
页码:20342 / 20353
页数:12
相关论文
共 45 条
[1]   Liver transplantation for hepatocellular carcinoma from livingdonor vs. deceased donor [J].
Akamatsu, Nobuhisa ;
Kokudo, Norihiro .
HEPATOBILIARY SURGERY AND NUTRITION, 2016, 5 (05) :422-428
[2]   circFBLIM1 act as a ceRNA to promote hepatocellular cancer progression by sponging miR-346 [J].
Bai, Ning ;
Peng, Eming ;
Qiu, Xingsheng ;
Lyu, Ning ;
Zhang, Zhejia ;
Tao, Yiming ;
Li, Xinying ;
Wang, Zhiming .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
[3]   Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy [J].
Blake, Stephen J. ;
Stannard, Kimberley ;
Liu, Jing ;
Allen, Stacey ;
Yong, Michelle C. R. ;
Mittal, Deepak ;
Aguilera, Amelia Roman ;
Miles, John J. ;
Lutzky, Viviana P. ;
de Andrade, Lucas Ferrari ;
Martinet, Ludovic ;
Colonna, Marco ;
Takeda, Kazuyoshi ;
Kuehnel, Florian ;
Gurlevik, Engin ;
Bernhardt, Guenter ;
Teng, Michele W. L. ;
Smyth, Mark J. .
CANCER DISCOVERY, 2016, 6 (04) :446-459
[4]   Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer [J].
Borghaei, H. ;
Paz-Ares, L. ;
Horn, L. ;
Spigel, D. R. ;
Steins, M. ;
Ready, N. E. ;
Chow, L. Q. ;
Vokes, E. E. ;
Felip, E. ;
Holgado, E. ;
Barlesi, F. ;
Kohlhaeufl, M. ;
Arrieta, O. ;
Burgio, M. A. ;
Fayette, J. ;
Lena, H. ;
Poddubskaya, E. ;
Gerber, D. E. ;
Gettinger, S. N. ;
Rudin, C. M. ;
Rizvi, N. ;
Crino, L. ;
Blumenschein, G. R. ;
Antonia, S. J. ;
Dorange, C. ;
Harbison, C. T. ;
Finckenstein, F. Graf ;
Brahmer, J. R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) :1627-1639
[5]   Surface Plasmon Resonance Sensor Based on a Novel D-Shaped Photonic Crystal Fiber for Low Refractive Index Detection [J].
Chen, Xin ;
Xia, Li ;
Li, Chen .
IEEE PHOTONICS JOURNAL, 2018, 10 (01)
[6]   Immunoregulation of Dendritic Cell Subsets by Inhibitory Receptors in Urothelial Cancer [J].
Chevalier, Mathieu F. ;
Bohner, Perrine ;
Pieraerts, Claire ;
Lhermitte, Benoit ;
Gourmaud, Jolanta ;
Nobile, Antoine ;
Rotman, Samuel ;
Cesson, Valerie ;
Martin, Virginie ;
Legris, Anne-Sophie ;
Dartiguenave, Florence ;
Gharbi, Dalila ;
De Leval, Laurence ;
Speiser, Daniel E. ;
Nardelli-Haefliger, Denise ;
Jichlinski, Patrice ;
Derre, Laurent .
EUROPEAN UROLOGY, 2017, 71 (06) :854-857
[7]   PD-1 immunobiology in autoimmune hepatitis and hepatocellular carcinoma [J].
Curran, Colleen S. ;
Sharon, Elad .
SEMINARS IN ONCOLOGY, 2017, 44 (06) :428-432
[8]   TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy [J].
Dougall, William C. ;
Kurtulus, Sema ;
Smyth, Mark J. ;
Anderson, Ana C. .
IMMUNOLOGICAL REVIEWS, 2017, 276 (01) :112-120
[9]   Microdissection-based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinoma [J].
Finkelstein, SD ;
Marsh, W ;
Demetris, AJ ;
Swalsky, PA ;
Sasatomi, E ;
Bonham, A ;
Subotin, M ;
Dvorchik, I .
HEPATOLOGY, 2003, 37 (04) :871-879
[10]   New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection [J].
Gan, Wei ;
Huang, Jin-Long ;
Zhang, Mei-Xia ;
Fu, Yi-Peng ;
Yi, Yong ;
Jing, Chu-Yu ;
Fan, Jia ;
Zhou, Jian ;
Qiu, Shuang-Jian .
JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (07) :1540-1547